Cardiology
New cardiology study findings recently were published by researchers at Washington Hospital Center, Division of Cardiology
Published in Cardiovascular Device Liability Week, July 15th, 2007
Investigators publish new data in the report "Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention. Aspirin and clopidogrel are proven to prevent thromboembolic events during percutaneous coronary intervention (PCI). Enzyme release of creatine kinase-MB (CK-MB) enzyme during PCI has been associated with an increased risk of future adverse cardiac events," researchers in the United States report.
"This study examined the correlation between measurements of aspirin resistance and the level of inhibition of the thienopyridine-specific P2Y12 platelet receptor and CK-MB...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Abdominal Aortic Aneurysm
Reports from Tokyo Women's Medical University, Department of Cardiology describe recent advances in abdominal aortic aneurysm - Abdominal Aortic Aneurysm Epidemiology
Data from Uppsala University, Department of Surgical Sciences provide new insights into abdominal aortic aneurysm epidemiology - Abdominal Aortic Aneurysm Epidemiology
Researchers from University of Missouri, Division of Vascular Surgery report details of new studies and findings in the area of abdominal aortic aneurysm epidemiology - Abdominal Aortic Aneurysm Risk Factors
Recent studies from University of Texas, Department of Surgery add new data to abdominal aortic aneurysm risk factors - Abdominal Aortic Aneurysm Risk Factors
Studies from Scientific Institute in the area of abdominal aortic aneurysm risk factors published - Adverse Drug Reactions
Research data from University of Kentucky, Department of Surgery update understanding of adverse drug reactions - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
